Skip Navigation LinksHome > July 2014 - Volume 29 - Issue 4 > Pharmacotherapy in the treatment of patients with borderline...
International Clinical Psychopharmacology:
doi: 10.1097/YIC.0000000000000021
Original Articles

Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices

Knappich, Moritza; Hörz-Sagstetter, Susannea,b; Schwerthöffer, Dirka; Leucht, Stefana; Rentrop, Michaela

Collapse Box

Abstract

Pharmacotherapy still seems to play a major role in the treatment of patients suffering from borderline personality disorder (BPD). However, little is known about psychiatrists’ detailed perspective on indication and significance of medication. A total of 233 psychiatrists in the city of Munich and in Upper Bavaria were asked by questionnaire about their treatment habits in the medical treatment of patients with BPD. One hundred and forty-one psychiatrists answered the questionnaire (60.5%). In total, 94% of BPD patients were treated with psychotropic medication. Psychiatrists predominantly saw an indication to prescribe antidepressants (98%), followed by antipsychotics, mood stabilizers, and benzodiazepines. Citalopram/escitalopram and quetiapine were mentioned most frequently. The results are discussed in conjunction with the international guidelines for the treatment of BPD.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.